Ardelyx reported $5.1M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Amgen USD 3.83B 130M Mar/2026
Ardelyx USD 5.1M 431K Dec/2025
aTyr Pharma USD 24.47M 51.21M Dec/2025
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Curis USD -7.88M 4.63M Dec/2025
Sanofi EUR 1.5B 2.29B Dec/2025
TG Therapeutics USD 34.8M 15.7M Mar/2026
United Therapeutics USD 325.8M 340.4M Mar/2026
Xoma USD -15.64M 5.56M Sep/2024